10-Q: Aflac's First Quarter 2025 Earnings Plunge Amid Investment Losses, Currency Headwinds

Aflac reports a significant drop in net earnings for Q1 2025, primarily due to net investment losses and unfavorable foreign currency translation.

Summary

• Aflac Incorporated reported net earnings of $29 million, or $0.05 per diluted share, for the first quarter of 2025, a significant decrease compared to $1.9 billion, or $3.25 per diluted share, in the first quarter of 2024.
• The decline was primarily attributed to net investment losses of $963 million in Q1 2025, contrasting with net investment gains of $951 million in Q1 2024.
• Total revenues decreased to $3.4 billion from $5.4 billion year-over-year.
• Adjusted earnings were $906 million, or $1.66 per diluted share, compared to $961 million, or $1.66 per diluted share, in the prior year.
• The average yen/dollar exchange rate weakened by 2.4% year-over-year, negatively impacting adjusted earnings per diluted share by $0.01.
• During the quarter, Aflac repurchased 8.5 million shares for $900 million.
• Shareholders' equity was $26.3 billion, or $48.55 per share, at the end of the quarter.
• The company's board declared a second quarter cash dividend of $0.58 per share, an increase of 16.0% compared to the same period in 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the dividend was increased and Aflac U.S. showed some growth, the significant drop in net earnings and the negative impact of investment losses and currency fluctuations weigh heavily on the overall sentiment.

Positives

• Aflac U.S. new annualized premium sales increased 3.5% year-over-year.
• The board of directors increased the second quarter dividend by 16.0% to $0.58 per share.
• Aflac U.S. annualized premiums in force increased 4.7% year-over-year.

Negatives

• Net earnings decreased significantly due to net investment losses.
• Total revenues decreased to $3.4 billion from $5.4 billion year-over-year.
• The weaker yen/dollar exchange rate negatively impacted adjusted earnings per diluted share by $0.01.

Risks

• Difficult conditions in global capital markets and the economy, including inflation, could impact future performance.
• Defaults and credit downgrades of investments pose a risk to the investment portfolio.
• Global fluctuations in interest rates and exposure to significant interest rate risk could affect profitability.
• Concentration of business in Japan exposes the company to risks associated with that market.
• Foreign currency fluctuations in the yen/dollar exchange rate can significantly impact reported results.

Future Outlook

The company expects the need for third sector products will continue to rise in the future and that the medical and cancer insurance products Aflac Japan provides will continue to be an important part of its product portfolio.

Industry Context

The report reflects the broader challenges faced by the insurance industry, including navigating volatile investment markets and managing the impact of currency fluctuations.

Comparison to Industry Standards

• Aflac's investment portfolio is primarily composed of fixed maturity securities, which is typical for insurance companies to match asset durations with policy liabilities.
• Comparable companies like Prudential Financial and MetLife also face similar challenges in managing investment portfolios and navigating currency risks, particularly with international operations.
• Aflac's RBC ratio and SMR are key indicators of financial health, similar to how other insurers are evaluated by regulators and rating agencies.
• The company's focus on third-sector products in Japan aligns with the trend of increasing demand for supplemental health insurance due to cost pressures on the healthcare system.

Stakeholder Impact

• Shareholders will see a lower return on equity due to decreased earnings.
• Policyholders are not expected to be directly impacted, as the company maintains strong capital levels.
• Employees may be affected by potential cost-cutting measures in response to lower profitability.

Next Steps

• The company plans to continue to maintain a population of unhedged U.S. dollar-denominated investments at Aflac Japan and to consider whether the amount of such investments should be increased or decreased relative to the Company's view of economic equity surplus in Aflac Japan in light of potentially rising hedge costs and other factors.
• The FSA will introduce an economic value-based solvency regime based on the Insurance Capital Standards (ICS) for insurance companies in Japan, with the initial report on the Economic Solvency Ratio (ESR) due as of March 31, 2026.

Key Dates

Keywords

Aflac, earnings, investment losses, financial results, premiums, insurance, Japan, U.S., share repurchase, dividends